Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist-Reference-Cited by-同舟云学术

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist

Published:2016-05-11 Issue:23 Volume:7 Page:35353-35368
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Grillo Elisabetta¹,Ravelli Cosetta¹,Corsini Michela²,Ballmer-Hofer Kurt³,Zammataro Luca⁴,Oreste Pasqua⁵,Zoppetti Giorgio⁵,Tobia Chiara¹,Ronca Roberto¹,Presta Marco¹²,Mitola Stefania¹

Affiliation:

1. Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, 25123, Italy

2. Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, National Institute of Neurosciences, University of Brescia, Brescia, 25123, Italy

3. Biomolecular Research, Molecular Cell Biology, Paul Scherrer Institut, Villigen, 5232, Switzerland

4. Center of Genomics Science of IIT@SEMM, Milan, 20139, Italy

5. Glycores2000, Milan, 20155 Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis;2024-07-08

2. Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis;2024-07-08

3. BMP4 and GREM1 are targets of SHH signaling and downstream regulators of collagen in the penis;The Journal of Sexual Medicine;2024-03-06

4. Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis;2024-01-05

5. GREM1 signaling in cancer: tumor promotor and suppressor?;Journal of Cell Communication and Signaling;2023-08-24